BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17692017)

  • 21. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.
    Peterson SL; Nguyen HX; Mendez OA; Anderson AJ
    J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RGMa inhibition promotes axonal growth and recovery after spinal cord injury.
    Hata K; Fujitani M; Yasuda Y; Doya H; Saito T; Yamagishi S; Mueller BK; Yamashita T
    J Cell Biol; 2006 Apr; 173(1):47-58. PubMed ID: 16585268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury.
    Schwab JM; Conrad S; Elbert T; Trautmann K; Meyermann R; Schluesener HJ
    Glia; 2004 Sep; 47(4):377-86. PubMed ID: 15293235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury.
    Hiraga A; Kuwabara S; Doya H; Kanai K; Fujitani M; Taniguchi J; Arai K; Mori M; Hattori T; Yamashita T
    J Peripher Nerv Syst; 2006 Sep; 11(3):217-24. PubMed ID: 16930283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling.
    Roloff F; Scheiblich H; Dewitz C; Dempewolf S; Stern M; Bicker G
    PLoS One; 2015; 10(2):e0118536. PubMed ID: 25714396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
    Walmsley AR; Mir AK
    Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho-ROCK inhibition in the treatment of spinal cord injury.
    Forgione N; Fehlings MG
    World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.
    Lingor P; Tönges L; Pieper N; Bermel C; Barski E; Planchamp V; Bähr M
    Brain; 2008 Jan; 131(Pt 1):250-63. PubMed ID: 18063589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter inhibitors in CNS axon regeneration failure.
    Xie F; Zheng B
    Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
    Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G; Tang WY
    Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting neurite growth inhibitors to induce CNS regeneration.
    Kastin AJ; Pan W
    Curr Pharm Des; 2005; 11(10):1247-53. PubMed ID: 15853681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming inhibitors in myelin to promote axonal regeneration.
    Domeniconi M; Filbin MT
    J Neurol Sci; 2005 Jun; 233(1-2):43-7. PubMed ID: 15949495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
    J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.